ADMT logo

ADM Tronics Unlimited, Inc. (ADMT) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

ADM Tronics Unlimited, Inc. (ADMT) ist im Healthcare-Sektor taetig, zuletzt notiert bei $ mit einer Marktkapitalisierung von 0. Bewertet mit 45/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.

Zuletzt analysiert: 16. März 2026
45/100 KI-Bewertung

ADM Tronics Unlimited, Inc. (ADMT) Gesundheitswesen & Pipeline-Uebersicht

CEOAndre' DiMino
Mitarbeiter30
HauptsitzNorthvale, US
IPO-Jahr1990

ADM Tronics Unlimited, Inc. develops and manufactures electronics for non-invasive medical applications and specialty chemicals. Operating in the healthcare sector, the company offers devices for diagnostics and therapeutics, alongside chemical products for medical and cosmetic uses, serving markets across the United States, Asia, Australia, and Europe.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

ADM Tronics Unlimited, Inc. presents a unique investment proposition within the medical devices and specialty chemicals sectors. The company's diverse product portfolio, spanning electronics, chemicals, and engineering services, offers multiple revenue streams. With a market capitalization of $0.01 billion and a negative P/E ratio of -900.65, the company's valuation reflects current challenges, indicated by a negative profit margin of -0.2%. However, a gross margin of 38.6% suggests potential for improved profitability. Growth catalysts include expansion of its medical device offerings and increased demand for its specialty chemical products. Key risks include its OTC market listing and limited financial disclosure.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Market capitalization of $0.01 billion indicates a micro-cap company with potential for high growth but also higher risk.
  • Negative P/E ratio of -900.65 reflects current unprofitability, requiring further investigation into the underlying causes and potential turnaround strategies.
  • Gross margin of 38.6% demonstrates the company's ability to generate revenue above the cost of goods sold, suggesting efficiency in production.
  • Beta of 0.23 indicates low volatility compared to the market, which may appeal to risk-averse investors.
  • The company operates in the Electronics, Chemical, and Engineering segments, diversifying its revenue streams and reducing dependence on a single product or market.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Diverse product portfolio across electronics, chemicals, and engineering.
  • Proprietary technology in medical devices and chemical formulations.
  • Long-standing experience in the medical and chemical industries.
  • Established customer relationships in various markets.

Schwaechen

  • Small market capitalization and limited financial resources.
  • Negative profitability and low revenue growth.
  • Dependence on OTC market listing.
  • Limited geographic diversification.

Katalysatoren

  • Upcoming: Potential FDA approval for new medical devices could drive revenue growth.
  • Ongoing: Expansion of distribution channels in Asia and Europe may increase market reach.
  • Ongoing: Increased demand for specialty chemical products due to environmental regulations.
  • Upcoming: Strategic partnerships with healthcare providers could enhance market penetration.

Risiken

  • Potential: Intense competition from larger and more established companies.
  • Ongoing: Stringent regulatory requirements and potential product liability claims.
  • Potential: Economic downturns and fluctuations in demand.
  • Ongoing: Technological obsolescence and changing customer preferences.
  • Ongoing: Risks associated with OTC market listing, including limited liquidity and disclosure.

Wachstumschancen

  • Expansion of Medical Device Offerings: ADM Tronics can capitalize on the growing demand for non-invasive medical devices by expanding its product portfolio and targeting new therapeutic areas. The global medical device market is projected to reach $600 billion by 2028, offering significant growth potential. By investing in research and development and obtaining regulatory approvals for new devices, ADM Tronics can increase its market share and revenue.
  • Increased Demand for Specialty Chemical Products: The company can leverage the increasing demand for water-based primers, adhesives, coatings, and resins in various industries, including healthcare and cosmetics. The global specialty chemicals market is expected to reach $900 billion by 2027, driven by stringent environmental regulations and demand for sustainable solutions. ADM Tronics can focus on developing innovative and environmentally friendly chemical products to capture a larger share of this market.
  • Geographic Expansion: ADM Tronics can expand its operations into new geographic markets, particularly in Asia and Europe, where demand for medical devices and specialty chemicals is growing rapidly. By establishing partnerships with local distributors and obtaining necessary regulatory approvals, the company can increase its global presence and revenue streams. This expansion should be strategic and phased, focusing on markets with favorable regulatory environments and growth potential.
  • Strategic Acquisitions: ADM Tronics can pursue strategic acquisitions of complementary businesses to expand its product portfolio, market reach, and technological capabilities. By acquiring companies with innovative technologies or established customer bases, ADM Tronics can accelerate its growth and enhance its competitive position. These acquisitions should be carefully evaluated to ensure they align with the company's strategic objectives and financial capabilities.
  • Enhanced Research and Development: ADM Tronics can invest in enhanced research and development activities to develop innovative products and technologies that address unmet needs in the medical devices and specialty chemicals markets. By collaborating with universities and research institutions, the company can accelerate its innovation pipeline and gain a competitive edge. This includes focusing on cutting-edge technologies like biocompatible materials and advanced diagnostic tools.

Chancen

  • Expansion into new therapeutic areas and geographic markets.
  • Increased demand for non-invasive medical devices and specialty chemicals.
  • Strategic acquisitions of complementary businesses.
  • Development of innovative and environmentally friendly products.

Risiken

  • Intense competition from larger and more established companies.
  • Stringent regulatory requirements and potential product liability claims.
  • Economic downturns and fluctuations in demand.
  • Technological obsolescence and changing customer preferences.

Wettbewerbsvorteile

  • Proprietary Technology: ADM Tronics owns proprietary technology in medical electronic therapeutic devices.
  • Specialized Chemical Formulations: The company has expertise in developing specialized water-based chemical formulations.
  • Regulatory Expertise: ADM Tronics possesses experience in navigating regulatory approval processes for medical devices.
  • Long-standing Customer Relationships: The company has established long-term relationships with customers in various industries.

Ueber ADMT

ADM Tronics Unlimited, Inc., founded in 1969 and headquartered in Northvale, New Jersey, operates as a developer, manufacturer, and seller of electronics, chemicals, and engineered products. The company's primary focus is on non-invasive medical applications, serving markets in the United States, Australia, Asia, and Europe. ADM Tronics operates through three segments: Electronics, Chemical, and Engineering. The Electronics segment offers proprietary devices used in diagnostics and therapeutics for both humans and animals, as well as electronic controllers for spas and hot tubs. The Chemical segment provides water-based primers, adhesives, coatings, resins, and chemical additives, including anti-static conductive paints and coatings. The Engineering segment focuses on research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies, including medical electronic therapeutic technology. Additionally, the company provides water-based adhesive and related topical formulations for maxillofacial prosthetic medical applications and professional makeup applications for film, TV, and theatrical productions.

Was das Unternehmen tut

  • Develops and manufactures electronic devices for non-invasive medical applications.
  • Produces water-based primers, adhesives, coatings, and resins.
  • Offers chemical additives and anti-static conductive paints.
  • Provides research, development, and engineering services for medical devices and electronics.
  • Creates water-based adhesive formulations for maxillofacial prosthetic medical applications.
  • Develops formulations for professional makeup applications in film, TV, and theater.

Geschaeftsmodell

  • Sales of proprietary electronic devices for medical diagnostics and therapeutics.
  • Revenue from the sale of specialty chemical products to various industries.
  • Service fees for research, development, and engineering services.
  • Licensing of medical electronic therapeutic technology.

Branchenkontext

ADM Tronics Unlimited, Inc. operates within the medical devices and specialty chemicals industries. The medical devices industry is characterized by technological innovation, stringent regulatory requirements, and increasing demand for non-invasive diagnostic and therapeutic solutions. The specialty chemicals industry is driven by demand for advanced materials and formulations across various applications, including healthcare and cosmetics. ADM Tronics' competitive landscape includes companies such as BIXT, BZYR, CVSI, DHBUF, and GBCS. The company's ability to navigate regulatory hurdles and develop innovative products will be crucial for success in these competitive markets.

Wichtige Kunden

  • Hospitals and clinics using medical diagnostic and therapeutic devices.
  • Spas and hot tub manufacturers using electronic controllers.
  • Manufacturers using water-based primers, adhesives, and coatings.
  • Film, TV, and theatrical productions using makeup formulations.
KI-Zuversicht: 69% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

ADM Tronics Unlimited, Inc. (ADMT) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer ADMT.

Kursziele

Wall-Street-Kurszielanalyse fuer ADMT.

MoonshotScore

45/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von ADMT auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Andre' DiMino

CEO

Andre' DiMino serves as the CEO of ADM Tronics Unlimited, Inc. His background includes extensive experience in managing and growing technology-focused companies. He has been instrumental in guiding ADM Tronics through various stages of development, focusing on innovation and strategic partnerships. His expertise spans across electronics, chemicals, and engineering, enabling him to effectively lead the company's diverse operations. He oversees a team of 30 employees, driving the company's vision and strategic initiatives.

Erfolgsbilanz: Under Andre' DiMino's leadership, ADM Tronics has focused on expanding its product portfolio and market reach. Key achievements include the development of proprietary medical devices and the establishment of strategic partnerships. He has also overseen the company's efforts to navigate regulatory approvals and maintain compliance. His strategic decisions have been aimed at driving long-term growth and enhancing shareholder value.

ADMT OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that ADM Tronics Unlimited, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements and less scrutiny, potentially leading to greater information asymmetry and volatility.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC-listed stock, ADM Tronics may experience lower trading volumes and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and at desired prices. Investors should be aware of potential illiquidity and the impact on transaction costs. The limited liquidity can also amplify price volatility, increasing the risk of significant price swings.
OTC-Risikofaktoren:
  • Limited Financial Disclosure: The lack of readily available financial information increases the difficulty of assessing the company's financial health and performance.
  • Lower Liquidity: Reduced trading volumes and wider bid-ask spreads can make it challenging to execute trades efficiently.
  • Higher Volatility: OTC stocks are generally more volatile than exchange-listed stocks, increasing the risk of significant price fluctuations.
  • Potential for Fraud: The lower regulatory oversight of the OTC market increases the risk of fraudulent activities and scams.
  • Limited Investor Protection: Investors in OTC stocks have less protection compared to those in exchange-listed stocks.
Sorgfaltspruefung-Checkliste:
  • Verify the company's registration and regulatory filings.
  • Review available financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the management team and their track record.
  • Understand the risks associated with investing in OTC stocks.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
Legitimitaetssignale:
  • Long Operating History: The company has been in operation since 1969, suggesting a degree of stability and experience.
  • Diverse Product Portfolio: ADM Tronics offers a range of products and services across different segments.
  • Proprietary Technology: The company owns proprietary technology in medical devices and chemical formulations.
  • Established Customer Relationships: ADM Tronics has established relationships with customers in various industries.

ADMT Healthcare Aktien-FAQ

What are the key factors to evaluate for ADMT?

ADM Tronics Unlimited, Inc. (ADMT) currently holds an AI score of 45/100, indicating low score. Key strength: Diverse product portfolio across electronics, chemicals, and engineering.. Primary risk to monitor: Potential: Intense competition from larger and more established companies.. This is not financial advice.

How frequently does ADMT data refresh on this page?

ADMT prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven ADMT's recent stock price performance?

Recent price movement in ADM Tronics Unlimited, Inc. (ADMT) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diverse product portfolio across electronics, chemicals, and engineering.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider ADMT overvalued or undervalued right now?

Determining whether ADM Tronics Unlimited, Inc. (ADMT) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying ADMT?

Before investing in ADM Tronics Unlimited, Inc. (ADMT), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding ADMT to a portfolio?

Potential reasons to consider ADM Tronics Unlimited, Inc. (ADMT) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Diverse product portfolio across electronics, chemicals, and engineering.. Additionally: Proprietary technology in medical devices and chemical formulations.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of ADMT?

Yes, most major brokerages offer fractional shares of ADM Tronics Unlimited, Inc. (ADMT) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track ADMT's earnings and financial reports?

ADM Tronics Unlimited, Inc. (ADMT) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for ADMT earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Information is based on available sources and may be subject to change.
  • OTC market data may be limited and less reliable than exchange-listed data.
  • AI analysis is pending and may provide additional insights in the future.
Datenquellen

Popular Stocks